Upload Avatar (500 x 500)
Ruixin Zhu
rxzhu@tongji.edu.cn
Chinese, English
Shanghai
Tongji University
Life Sciences
  • 2001 - Bachelor of Chemistry, Lanzhou University
  • 2007 - PhD in Computational Chemistry, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences
  • Published the first undergraduate textbook on Computer-Aided Drug Design in China
  • 2007-2008 - Shanghai Center for Bioinformation Technology, Researcher
  • 2008-Present - School of Life Sciences and Technology, Tongji University, Professor
  • 2022 - Included in 'Top 100 International Cooperation Papers of Tongji University 2021'
  • 2019 - Outstanding Doctoral Dissertation Supervisor, Tongji University
  • 2017 - Annual Outstanding Research Worker, School of Life Sciences and Technology, Tongji University
Artificial Intelligence and Drug Design
Artificial Intelligence and Microbiome
Data-Intensive Research Algorithms and Platform Development
  • Enhanced microbiota profiling in patients with quiescent Crohn's disease through comparison with paired healthy first-degree relatives, Ruixin Zhu et al., 2024
  • The search for authentic microbiome–disease relationships, Ruixin Zhu et al., 2024
  • Identification and validation of microbial biomarkers from cross-cohort datasets using xMarkerFinder, Ruixin Zhu et al., 2024
  • Integrative multi-omics deciphers the spatial characteristics of host-gut microbiota interactions in Crohn’s disease, Ruixin Zhu et al., 2023
  • Targeting Keystone Species Helps Restore the Dysbiosis of Butyrate‐Producing Bacteria in Nonalcoholic Fatty Liver Disease, Ruixin Zhu et al., 2022
  • Multi-kingdom microbiota analyses identify bacterial-fungal interactions and biomarkers of colorectal cancer across cohorts, Ruixin Zhu et al., 2022
  • Identification of microbial markers across populations in early detection of colorectal cancer, Ruixin Zhu et al., 2021
  • Phylogenetic analyses with systematic taxon sampling show that mitochondria branch within Alphaproteobacteria, Ruixin Zhu et al., 2020
  • Suppressed hepatic bile acid signalling despite elevated production of primary and secondary bile acids in NAFLD, Ruixin Zhu et al., 2018
Ai Drug Design Non-Alcoholic Fatty Liver Inflammatory Bowel Disease Drug Screening Microbiome Non-Invasive Diagnostics Host-Microbe Interaction Synthetic Biology Data-Driven Research

Contact us

Let's talk!
* Required
* Required
* Required
* Invalid email address
By submitting this form, you agree that IoT ONE may contact you with insights and marketing messaging.
No thanks, I don't want to receive any marketing emails from IoT ONE.
Submit

Thank you for your message!
We will contact you soon.